https://www.selleckchem.com/pr....oducts/crenolanib-cp
1 ± 3.3 (P = .18), with 6.7 ± 18.3 versus 7.0 ± 43.0 in-hospital days, for DS and RYGB, respectively. An increased risk of malnutrition/malabsorption requiring inpatient care (2.8% versus .2%, odds ratio 12.3 [3.3-45.7]) and greater need for additional abdominal surgery (25.8% versus 15.3%, odds ratio 2.0 [1.5-2.7]) was observed for DS. However, QoL was more improved after DS. CONCLUSION DS was associated with more early complications because of more open surgery, but long-term requirement of inpatient care was similar to R
Like
Comment
Share
